HIV/AIDs combination drugs

HIV/AIDs combination drugs

The Ministry of Health said it has reached a decision to phase out adult first-line HIV treatment combination TLE (tenofovir-lamivudine-efavirenz) in favour of the more effective medication that contains dolutegravir – TLD.

The Ministry of Health said it has reached a decision to phase out adult first-line HIV treatment combination TLE (tenofovir-lamivudine-efavirenz) in favour of the more effective medication that contains dolutegravir – TLD.